For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 0.5% SPL7013 Gel | 0.5% SPL7013 Gel: Vaginal gel | None | None | 0 | 32 | 6 | 32 | View |
| 1.0% SPL7013 Gel | 1.0% SPL7013 Gel: Vaginal gel | None | None | 0 | 32 | 4 | 32 | View |
| 3.0% SPL7013 Gel | 3.0% SPL7013 Gel: Vaginal gel | None | None | 0 | 29 | 5 | 29 | View |
| Placebo Gel | Placebo Gel: Vaginal gel | None | None | 0 | 32 | 4 | 32 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Vulvovaginal pruritus | None | Reproductive system and breast disorders | None | View |
| Vulvovaginal burning sensation | None | Reproductive system and breast disorders | None | View |
| Vulvovaginal candidiasis | None | Infections and infestations | None | View |
| Metrorrhagia | None | Reproductive system and breast disorders | None | View |